Corteva, Inc. filings document the reporting obligations of a NYSE-listed agriculture company with common stock registered under the Exchange Act. Form 8-K reports cover quarterly and annual operating results, furnished earnings releases, financial statement schedules, annual meeting voting results, executive officer changes, board matters, dividend-related disclosures, and strategic separation planning for its agriculture businesses.
The company's definitive proxy materials provide governance and compensation disclosures, including director elections, shareholder proposals, executive compensation tables, equity awards, board oversight, and stockholder voting matters. Corteva's filing record also identifies its capital structure, including common stock and preferred stock matters involving EIDP, Inc., a wholly owned subsidiary.
Capital World Investors reports beneficial ownership of 36,863,390 shares of Corteva common stock, representing 5.5% of the class. The filing states the stake is based on 03/31/2026 figures and that Capital World Investors holds 36,479,646 shares with sole voting power and 36,863,390 shares with sole dispositive power.
The filing is a Schedule 13G disclosure signed May 13, 2026, reporting institutional passive ownership of Corteva common shares.
FMR LLC reports beneficial ownership of 35,175,070.01 shares (5.2%) of Corteva, as of 03/31/2026. The filing on a Schedule 13G shows sole voting power of 31,857,057.60 shares and sole dispositive power of 35,175,070.01 shares. Signature dates appear on the filing as 05/05/2026.
Corteva, Inc. reported a strong first quarter of 2026 with broad-based growth and reaffirmed its full-year outlook. Net sales were $4.905 billion, up 11% from 1Q 2025, driven by 7% organic sales growth. GAAP income from continuing operations was $725 million, or $1.07 per diluted share, versus $0.97 a year ago.
Non-GAAP results were even stronger: Operating EBITDA rose to $1.438 billion, up 21%, and Operating EPS increased to $1.50 from $1.13, a 33% gain. Seed net sales grew 12% to $3.023 billion and Crop Protection net sales grew 10% to $1.882 billion, with higher volumes in all regions offsetting some price pressure in Latin America.
The company reaffirmed its full-year 2026 guidance, expecting Operating EBITDA of $4.0–$4.2 billion and Operating EPS of $3.45–$3.70, both implying about 7% growth at the midpoint. Corteva plans to repurchase approximately $500 million of shares in the first half of 2026, while also preparing for a planned separation into two companies in the second half of 2026, including a $1.5 billion discretionary contribution to its principal U.S. pension plan and estimated one-time separation costs of about $350 million.
Corteva, Inc. director Nayyar Nayaki R reported an acquisition of 401.1850 stock units tied to Corteva common stock, valued using a reference price of $81.0100 per share. The units were credited under the company’s Stock Accumulation and Deferred Compensation Plan for Directors as deferred cash compensation. Following this award, the director’s direct holdings increased to 36,254.5784 shares or stock units.
Corteva, Inc. director Marcos M. Lutz reported a routine tax-related share disposition. On the vesting of previously granted restricted stock units, the issuer withheld 906 shares of Common Stock to pay taxes, valued at $81.01 per share. After this withholding, Lutz directly holds about 63,053 shares of Corteva common stock.
Corteva, Inc. director Janet Plaut Giesselman reported receiving an award of 95.6672 shares of Common Stock on April 30, 2026. These represent stock units acquired under Corteva’s Stock Accumulation and Deferred Compensation Plan for Directors, where non-employee directors can defer cash fees into stock units.
After this grant, Giesselman directly holds a total of 20,102.5700 shares of Corteva common stock. The stock units were valued using the closing price of $81.01 per share on the date the cash compensation would otherwise have been paid.
Corteva, Inc. director Klaus A. Engel reported a routine tax-related share disposition linked to equity compensation. On the vesting of previously granted restricted stock units, 906 shares of common stock were withheld by the company to cover taxes, at a value of $81.01 per share. These shares were not sold on the open market. After this withholding, Engel directly holds 40,218.9582 shares of Corteva common stock.
Corteva, Inc. held its Annual Meeting of Stockholders on April 28, 2026. As of the March 9, 2026 record date, 671,356,502 common shares were outstanding, and 598,586,252 shares were voted in person or by proxy, representing 89.16% of shares entitled to vote.
Stockholders elected 12 directors, each receiving a substantial majority of votes cast, and approved on an advisory basis the compensation of the named executive officers. They also supported holding the say-on-pay vote every 1 year and ratified PricewaterhouseCoopers LLP as independent registered public accounting firm for 2026.
Corteva, Inc. director David C. Everitt reported an acquisition of 2,350 shares of common stock as a grant or award, with no purchase price per share shown. This is a compensation-related stock award rather than an open-market purchase.
The filing notes that the total includes 158.0986 shares acquired through dividend reinvestment, bringing his directly owned position to 19,738.3965 shares after the transaction. This reflects a modest increase in his equity stake in the company.
Corteva, Inc. director Pat Ward reported routine equity compensation and updated holdings. Ward received a grant or award of 2,350 shares of Corteva common stock at a stated price of $0.00 per share, increasing direct ownership to 38,432.3983 shares.
The filing also shows 1 share of common stock held indirectly by Ward’s spouse. A footnote explains that these holdings include the acquisition of 324.7033 shares pursuant to dividend reinvestment, reflecting automatic share accumulation rather than open‑market buying.